Literature DB >> 12560075

Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE.

R Scott Houliston1, Robert S Hodges, Frances J Sharom, James H Davis.   

Abstract

A single mutation within the transmembrane region of the Neu receptor (Val664-->Glu) is known to enhance tyrosine kinase activity, by promoting receptor dimerization. In order to gain insight into potential structural changes that arise as a result of the mutation, peptides corresponding to the complete transmembrane domain of proto-oncogenic and mutant forms of Neu have been studied by 1H nuclear magnetic resonance in the solvent trifluoroethanol (TFE). The chemical shifts are similar for both forms of the peptide, with the exception of amide residues close to the mutation site. Both peptides adopt a helical conformation, with a distinct bend one turn downstream of the mutation site. This deformation gives rise to several nuclear Overhauser effects, the majority of which were detected in both peptides, that are atypical for a straight canonical alpha-helix. Our data in this solvent do not support a conformational change in the transmembrane domain of monomeric Neu as a result of the mutation. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis indicates that proto-oncogenic Neu peptides have a higher propensity to oligomerize in the solvent TFE than the Glu664 oncogenic form.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560075     DOI: 10.1016/s0014-5793(02)03852-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  The transmembrane domain of Neu in a lipid bilayer: molecular dynamics simulations.

Authors:  Bryan M van der Ende; Frances J Sharom; James H Davis
Journal:  Eur Biophys J       Date:  2004-06-09       Impact factor: 1.733

2.  Dimerization of Neu/Erb2 transmembrane domain is controlled by membrane curvature.

Authors:  Lucie Khemtémourian; Sébastien Buchoux; Fabien Aussenac; Erick J Dufourc
Journal:  Eur Biophys J       Date:  2006-11-08       Impact factor: 2.095

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.